| NCT Number | NCT06560866 |
| Lead Sponsor | Chestnut Health Systems
Collaborators: National Institute on Drug Abuse (NIDA) |
| Conditions | Substance-Related Disorders |
| Enrollment | 260 participants |
| Start Date | 2023-11-24 |
| Primary Completion | 2027-10-30 (estimated) |
| Study Completion | 2028-01-30 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-24 |